Effect of thrombolytic therapy on the risk of cardiac rupture and mortality in older patients with first acute myocardial infarction

European Heart Journal

Volumn 26, Issue 17, 2005, Pages 1705-1711

  Bueno, Héctor ^a   Martínez Sellés, Manuel ^a   Pérez David, Esther ^a   López Palop, Ramón ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

Cardiac rupture; Elderly; Myocardial infarction; Primary angioplasty; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ANISTREPLASE; FIBRINOLYTIC AGENT; HEPARIN; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; AGED; ARTICLE; CARDIOGENIC SHOCK; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FIBRINOLYTIC THERAPY; HEART MUSCLE INJURY; HEART MUSCLE REPERFUSION; HEART PAPILLARY MUSCLE; HEART RUPTURE; HEART VENTRICLE SEPTUM RUPTURE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAUSE OF DEATH; EPIDEMIOLOGIC METHODS; FEMALE; HEART RUPTURE, POST-INFARCTION; HUMANS; MALE; MYOCARDIAL INFARCTION; SPAIN; THROMBOLYTIC THERAPY; TREATMENT OUTCOME;

EID: 24044495250     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/eurheartj/ehi284     Document Type: Article

References (32)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1000 patients. Lancet 1994;343:311-322.
2. Califf RM, Topol EJ, George BS, Boswick JM, Abbottsmith C, Sigmon KN, Candela R, Masek R, Kereiakes D, O'Neill WW et al. Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction. Am J Med 1988;85:354-359.
3. Anderson JL, Karagounis L, Allen A, Bradford MJ, Menlove RL, Pryor TA. Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis. Am J Cardiol 1991;68:166-170.
4. De Jaegere PP, Arnold AA, Balk AH, Simoons ML. Intracranial hemorrhage in association with thrombolytic therapy: incidence and clinical predictive factors. J Am Coll Cardiol 1992;19:289-294.
5. Maggioni AP, Franzosi MG, Santoro E, White H, Van de Werf F, Tognoni G. The risk of stroke in patients with acute myocardial infarction after thrombolytic and antithrombotic treatment. N Engl J Med 1992;327:1-6.
6. Lesnefsky EJ, Lundergan CF, Hodgson JM, Nair R, Reiner JS, Greenhouse SW, Califf RM, Ross AM. Increased left ventricular dysfunction in elderly patients despite succesful thrombolysis: the GUSTO-1 angiographic experience. J Am Coll Cardiol 1996;28:331-337.
7. White HD. Thrombolytic therapy in the elderly. Lancet 2000;356:2028-2030.
8. Stenestrand U, Wallentin L for the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RISK-HIA). Fibrinolytic therapy in patients 75 years and older with ST-segment-elevation myocardial infarction. One-year follow-up of a large prospective cohort. Arch Intern Med 2003;163:965-971.
9. Thiemann DR, Coresh J, Schulman SP, Gerstenblith G, Oetgen WJ, Powe NR. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation 2000;101:2239-2246.
10. Berger AK, Radford MJ, Wang Y, Krumholz HM. Thrombolytic therapy in older patients. J Am Coll Cardiol 2000;36:366-374.
11. Soumerai SB, McLaughlin TJ, Ross-Degnan D, Christiansen CL, Gurwitz JH. Effectiveness of thrombolytic therapy for acute myocardial infarction in the elderly: cause for concern in the old-old. Arch Intern Med 2002;162:561-566.
12. Bueno H, Vidán MT, Almazán A, López-Sendón JL, Delcán JL. Influence of sex on the short-term outcome of elderly patients with a first acute myocardial infarction. Circulation 1995;92:1133-1140.
13. Bueno H, López-Palop R, Bermejo J, López-Sendón JL, Delcán JL. In-hospital outcome of elderly patients with acute inferior myocardial infarction and right ventricular involvement. Circulation 1997;96:436-441.
14. López-Sendón J, González A, López de Sá E, Coma-Canella I, Roldán I, Domínguez F, Maqueda I, Martín Jadraque L. Diagnosis of subacute ventricular wall rupture after acute myocardial infarction: sensitivity and specificity of clinical, hemodynamic and echocardiographic criteria. J Am Coll Cardiol 1992;19:1145-1153.
15. Figueras J, Curós A, Cortadellas J, Soler-Soler J. Reliability of electromechanical dissociation in the diagnosis of left ventricular free wall rupture in acute myocardial infarction. Am Heart J 1996;131:861-864.
16. Honan MB, Harrell FE Jr, Reimer KA, Califf RM, Mark DB, Pryor DB, Hlatky MA. Cardiac rupture, mortality and the timing of thrombolytic therapy: a meta-analysis. J Am Coll Cardiol 1990;16:359-367.
17. Solodky A, Behar S, Herz I, Assali A, Porter A, Hod H, Boyko V, Battler A, Birnbaum Y. Comparison of incidence of cardiac rupture among patients with acute myocardial infarction treated by thrombolysis versus percutaneous transluminal coronary angioplasty. Am J Cardiol 2001;87:1105-1108.
18. Becker RC, Hochman JS, Cannon CP, Spencer FA, Ball SP, Rizzo MJ, Antman EM. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: Observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study. J Am Coll Cardiol 1999;33:479-487.
19. Pohjola-Sintonen S, Muller JE, Stone PH, Willich SN, Antman EM, Davis VG, Parker CB, Braunwald E. Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size. Am Heart J 1989;117:809-818.
20. Becker RC, Gore JM, Lambrew C, Weaver WD, Rubison RM, French WJ, Tiefenbrunn AJ, Bowlby LJ, Rogers WJ. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol 1996;27:1321-1326.
21. Slater J, Brown RJ, Antonelli TA, Menon V, Boland J, Col J, Dzavik V, Greenberg M, Menegus M, Connery C, Hochman JS. Cardiogenic shock due to cardiac free-wall rupture or tamponade after acute myocardial infarction: a report from the SHOCK Trial Registry. Should we emergently revascularize occluded coronaries for cardiogenic shock? J Am Coll Cardiol 2000;36(Suppl. 3A):1117-1122.
22. Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. The Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-2). N Engl J Med 1993;329:1442-1448.
23. Becker RC, Charlesworth A, Wilcox RG, Hampton J, Skene A, Gore JM, Topol EJ. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study. J Am Coll Cardiol 1995;25:1063-1068.
24. Massel D. Cardiac rupture and time to thrombolytic treatment. J Am Coll Cardiol 1991;17:1671-1672.
25. Pollak H. Thrombolysis, the risk of rupture and other risks. J Am Coll Cardiol 1997;29:221.
26. Yusuf S, Collins R, Furberg C, Stampfer MJ, Goldhaber SZ, Hennekens CH. Intravenous and intracoronary fibrinolytic therapy in acute myocardial infarction: overview of results on mortality, reinfarction and side-effects from 33 randomized controlled trials. Eur Heart J 1985;6:556-585.
27. Pollak H, Nobis H, Mlczoch J. Frequency of left ventricular free wall rupture complicating acute myocardial infarction since the advent of thrombolysis. Am J Cardiol 1994;74:184-186.
28. Massel DR. How sound is the evidence that thrombolysis increases the risk of cardiac rupture? Br Heart J 1993;69:284-287.
29. Nakatsuchi Y, Minamino T, Fujii K, Negoro S. Clinicopathological characterization of cardiac free wall rupture in patients with acute myocardial infarction: difference between early and late phase rupture, Int J Cardiol 1994;47(Suppl. 1):S33-S38.
30. Moreno R, López-Sendón J, García E, Pérez de Isla L, López de Sá E, Ortega A, Moreno M, Rubio R, Soriano J, Abeytua M, García-Fernández MA. Primary angioplasty reduces the risk of left ventricular free wall rupture compared with thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2002;39:598-603.
31. Yip HK, Fang CY, Tsai KT, Chang HW, Yeh KH, Fu M, Wu CJ. The potential impact of primary percutaneous coronary intervention on ventricular septal rupture complicating acute myocardial infarction. Chest 2004;125:1622-1628.
32. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. Lancet 1988;1:921-923.